Use access key #2 to skip to page content.
$20.78 0.19 (0.92%)
7/3/2008 1:01 PM

Bristol-Myers Squibb Co. (BMY)

CAPS Rating:
****

The Company, through its divisions and subsidiaries, is engaged in the discovery, development, licensing, manufacturing, marketing, distribution and sale of pharmaceuticals and other health care related products.

View All Commentary (BMY)

Recs

0

Avatar jsIRA (< 20) Submitted: 5/05/08 11:45 PM : Outperform Start Price: $23.60 BMY Score: -2.11

Undervalued drug company.

Report this Post Replies: 0 | Reply

Featured Broker Partners